Fennec Pharmaceuticals

FENCNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$368.207 M

$10.51 -4.54%

Close of 23 Sept 2026

Revenue

$44.6M

#2767 by revenue

Earnings

-$9.74B

Loss-making

Shares outstanding

35,067,159

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#76Artiva BiotherapeuticsARTV$377.4M
#77Cabaletta BioCABA$376.4M
#78Fennec PharmaceuticalsFENC$368.2M
#79OcugenOCGN$339.1M
#80Century TherapeuticsIPSC$318.7M

What if Fennec Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $29.8T

$851,941.74

Per share 81,060× higher

Bitcoin $1.69T

$48,356.46

Per share 4,601× higher

Nvidia $5.43T

$155,129.05

Per share 14,760× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Fennec Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 24 Sept 2026. Read the methodology.